100 episodes
Running Through Walls Venrock, a venture capital firm
-
- Business
-
-
4.8 • 61 Ratings
-
Running Through Walls is a Venrock podcast featuring candid conversations between investors and entrepreneurs. Each episode, we offer a behind-the-scenes look at the breakthroughs, challenges and nuttiness associated with building and growing companies. Venture capital firm Venrock has been investing in entrepreneurs across technology and healthcare since 1969.
-
If You’re Going to Bet on Anyone, Bet on Yourself
David Stark, Chief Medical Officer at Morgan Stanley, speaks with Venrock partner Bob Kocher to discuss his career journey from practicing medicine to taking a non-clinical role in business. Stark shares how he views his role as Chief Medical Officer, advice for other doctors who want to transition out of practicing medicine, what he’s proudest of at Morgan Stanley and more.
-
Know What Problems You’re Solving
Alex Rosemblat, former Chief Marketing Officer at Datadog, speaks with Venrock partner Ethan Batraski to discuss his 11-year run at the helm of Datadog’s Marketing Team and what’s next for his career. Rosemblat shares insights into leading Datadog’s go-to-market strategy, advice for other marketing leaders tackling this for a new product or company for the first time, his biggest learning from Datadog and more. During the conversation, Rosemblat recommended Digital CMO's Guide to Marketing Measurement by Bryan Semple.
Book mentioned: https://vnrk.co/3VuFvxg -
Be Planful as Early as Possible
Heather Turner, CEO at Carmot Therapeutics, speaks with Venrock partner Nimish Shah to discuss her time as CEO. Turner shares how she guided the company through its acquisition by Roche, advice for other CEOs on the verge of an acquisition, her perspective on the GLP-1 market and what excites her about the future of biotech.
-
Think Big, Focus Small
Mark McKenna, chairman and CEO at Mirador Therapeutics, speaks with Venrock partner Nimish Shah to discuss his most recent role at Prometheus Biosciences and the beginning of his new company, Mirador. McKenna shares a behind-the-scenes look into leading Prometheus during its acquisition by Merck, why he started Mirador Therapeutics, advice for other CEOs, what he values in a team and more.
-
Healthcare Prognosis 2024
We have a special episode today because Venrock’s 8th annual Healthcare Prognosis results are in! From drugs (e.g., GLP-1s, pricing negotiations) to fundraising and optimism around the equity market to cybersecurity and AI regulations - this year’s survey covers it all. In this episode, partners Bryan Roberts and Bob Kocher sit down to share their perspectives on the most interesting findings.
-
Selectively Ignore to Positively Disrupt
Sami Inkinen, founder and CEO of Virta Health, speaks with Venrock partner Bob Kocher to discuss how Virta has evolved since he was on the podcast seven years ago. Inkinen shares how he views the GLP-1 craze, insights on his go-to-market strategy, advice for founders entering the healthcare market, and how Virta uses AI and technology.
Customer Reviews
Inspiring & Real
Venrock is doing great work here! Each and every episode serves up huge helpings of inspiration combined with tangible advice we can all apply to our own lives and businesses. If you're looking for your next favorite podcast you're in the right place. Thanks for putting out such a wonderful show - keep up the great work!
LEGENDARY work
As a top venture captial firm, the folks at Venrock live and work and the intersection of new technology, new business and new category ideas. This wonderful podcast is one of my go-to's. THANKS VENROCK!
Awesome series!
Very informative, motivating and well timed series! Being a small business owner and having a son who starts business school soon, I found all episodes to be extremely informative. Great listening, can't wait for the next!